Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD [Phase 4]
Phase 4 trial evaluating add-on Opicapone 50 mg or extra L-DOPA 100 mg for wearing-off in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Voice Treatment for Parkinson's Disease [NA]
A completed clinical trial from University of Massachusetts on a voice treatment for idiopathic Parkinson disease with posted results.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) [Phase 2]
A Phase 2 clinical trial update examining relationships between neuropsychological testing and imaging modalities in Alzheimer and Parkinson…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease [Phase 3]
A Phase 3 clinical trial evaluating continuous apomorphine infusion for cognitive and neuropsychological outcomes in Parkinson's disease has…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Body Weight Gain, Parkinson, Subthalamic Stimulation [Phase 2]
Phase 2 clinical trial update related to body weight gain in Parkinson's disease with subthalamic stimulation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Effect of Safinamide on Parkinson's Disease Related Chronic Pain [Phase 4]
Phase 4 clinical trial investigating the effect of safinamide on Parkinson's disease-related chronic pain has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: GRoningen Early-PD Ambroxol Treatment [Phase 2, Phase 3]
Clinical trial update for Ambroxol treatment in Parkinson's disease (Phase 2/3) sponsored by University Medical Center Groningen.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate [Phase 4]
Phase 4 trial update evaluating sodium oxybate for REM Sleep Behavior Disorder with Parkinson's disease; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: [18F]MC225-PET in Neurodegenerative Disease [Phase 1, Phase 2]
Early-phase trial update for [18F]MC225-PET imaging in neurodegenerative diseases, including Alzheimer’s disease and related conditions (Pha…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Hypoestes Rosea Powder in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease [Phase 2]
A Phase 2 long-term safety study of ND0612 delivered by continuous subcutaneous infusion in advanced Parkinson's disease has results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD [Phase 3]
A Phase 3 study completed evaluating the effectiveness and safety of LY03003 in patients with early primary Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Antidepressants Trial in Parkinson's Disease [Phase 3]
Phase 3 clinical trial investigating antidepressants for depression in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluated relative bioavailability of ropinirole implants versus oral ropinirole in Parkinson's disease patient…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Chronic Effects of DBS in Parkinson's Disease and Dystonia [NA]
Clinical trial update on chronic effects of deep brain stimulation in Parkinson's disease and dystonia, with completed status and posted res…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: PPMI Tau PET Imaging [Phase 2]
Phase 2 trial update on tau PET imaging in Parkinson's disease completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease [Phase 3]
Phase 3 clinical trial evaluating buspirone for treatment of iatrogenic dyskinesias in advanced Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease [Phase 2, Phase 3]
Clinical trial evaluating safety and tolerability of hydrogen in Parkinson's disease was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating OC Oral Solution for reducing sialorrhoea in Parkinson's disease; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating safety, tolerability, and efficacy of two daily doses of P2B001 in early Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic [Phase 2]
A Phase 2 clinical trial investigates a multi-strain probiotic to treat anxiety in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Physical Therapy and Deep Brain Stimulation in Parkinson Disease [NA]
A completed clinical trial evaluating physical therapy and deep brain stimulation in Parkinson disease with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: A Phase 3 Study With P2B001 in Subjects With Early Parkinson's [Phase 3]
Phase 3 trial completed for P2B001 in early Parkinson's disease with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Parkinson's Disease Inpatient Clinical Knowledge and Management [NA]
A terminated clinical trial related to Parkinson disease with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study [Phase 4]
A Phase 4 crossover trial comparing Parcopa to carbidopa-levodopa in Parkinson's disease; results have been posted.